This site utilizes javascript for its functionality. You must enable javascript in order for it to function.


Welcome to IPRO's Management of Anticoagulation in the Peri-Procedural Period app.

MAPPP app is referenced in the Perioperative Management of the Antithrombotic Therapy, CHEST Guideline. Volume 162, Issue 5, E207-E243, November 1, 2022 as an online tool to help improve standardization of perioperative anticoagulant management.

Click here to try the web-based version now!

Despite the considerable efficacy of antithrombotics and the increased number of oral anticoagulants now available, preventable bleeding and thrombotic events are still unacceptably common. While recently marketed agents require less laboratory monitoring, problems with the clinical management of anticoagulated patients persist, particularly in the peri-procedural period.

Surgery and invasive medical interventions increase the risk of bleeding, while withholding anticoagulants increases the risk of thrombosis due to the underlying condition(s) for which anticoagulation was originally prescribed. The clinical team must therefore balance these competing risks and make educated decisions regarding the decision to interrupt oral anticoagulation for a medical procedure and, if interrupted, whether to "bridge" anticoagulation with injectable anticoagulants, such as low molecular weight heparin (LMWH) in warfarin treated patients.

This guide is intended to:

  • Assist clinicians in the simultaneous evaluation of procedure-related bleeding risk and underlying risk of thrombosis
  • Guide decisions regarding the interruption of anticoagulation and the use of anticoagulant "bridging"
  • Provide detailed guidance for drug dosing and laboratory monitoring in the peri-procedural period
  • Encourage clear communication between clinicians involved in prescribing anticoagulants and performing invasive procedures

This material was created by the multidisciplinary members of the Peri-Procedural Task Force of the New York State Anticoagulation Coalition and IPRO, the Medicare Quality Improvement Organization for New York State, under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services. The contents do not necessarily reflect CMS policy. 10SOW-NY-AIM-7.3-14-01

Browser Requirements

To view this app in your browser properly, you must have Javascript enabled as well as use one of the supported browsers:

  • Google Chrome - latest version
  • Mozilla Firefox - latest version
  • Microsoft Internet Explorer - version 10+
  • Microsoft Edge - version 12+

Corporate Headquarters
  • 1979 Marcus Avenue
  • Lake Success, NY 11042-1072
Phone: (516) 326-7767
TTY: (516) 326-6182
Fax: (516) 328-2310
Email Us
Regional Offices
Albany, NY
  • 20 Corporate Woods Blvd
  • Albany, NY 12211-2370
Phone: (518) 426-3300
Fax: (518) 426-3418
Hamden, CT
  • 1952 Whitney Avenue, 2nd Floor
  • Hamden, CT 06517
Phone: (203) 387-9332
Fax: (203) 389-9902
Morrisville, NC
  • 909 Aviation Parkway, Suite 300
  • Morrisville, NC 27560
Phone: (919) 388-9899
Fax: (919) 388-9637
Princeton, NJ
  • 4385 US 1 South
  • Princeton, NJ 08540
Phone: (609) 452-8782
Lumetra - San Francisco, CA
  • 550 Kearny Street, Suite 300
  • San Francisco, CA 94108-4429
Phone: (415) 677-2000
Fax: (415) 677-2191